Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$263.21 MCurrent assets$630.95 MLiabilities$975.61 MAssets$1.74 BNon-current liabilities$712.40 MEquity$768.16 MNon-current assets$1.11 BGross equity(calculated)$1.26 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoriesAccounts receivable, netShort-term investmentsPrepaid expenses and other assetsIncome tax refunds and depositsRestricted short-term investmentsRestricted cashGoodwill and intangible assets, netProperty, plant, and equipmentOperating lease right-of-use assetsDeferred tax assetsOther assetsFinance lease right-of-use assetsAccounts payable and accrued liabilitiesCurrent portion of operating lease liabilitiesCurrent portion of long-term debtIncome taxes payableLong-term debt, net of current portion and unamortized debt issuance costsLong-term operating lease liabilities, net of current portionOther long-term liabilitiesLong-term reserve for income tax liabilitiesRetained earningsAdditional paid-in capitalCommon stock: par value $0.0001; 300,000,000 shares authorized; 62,306,254 and 42,532,225 shares issued and outstanding, respectively, as of June 30, 2026 and 61,779,883 and 45,645,497 shares issued and outstanding, respectively, as of December 31, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stockAccumulated other comprehensive lossCash and cash equivalentsCash and cash equivalents$223.61 MAccounts payable and accrued liabilitiesAccounts payable and accrued liabilities$251.37 MCurrent liabilitiesCurrent liabilities$263.21 MInventoriesInventories$179.91 MCurrent portion of operating lease liabilitiesCurrent portion of operating lease liabilities$8.80 MCurrent assetsCurrent assets$630.95 MLiabilitiesLiabilities$975.61 MAccounts receivable, netAccounts receivable, net$144.86 MCurrent portion of long-term debtCurrent portion of long-term debt$2.49 MShort-term investmentsShort-term investments$66.51 MIncome taxes payableIncome taxes payable$546.00 KAssetsAssets$1.74 BPrepaid expenses and other assetsPrepaid expenses and other assets$11.00 MNon-current liabilitiesNon-current liabilities$712.40 MIncome tax refunds and depositsIncome tax refunds and deposits$2.63 MLong-term debt, net of current portion and unamortized debt issuance costsLong-term debt, net$609.56 MRestricted short-term investmentsRestricted short-term investments$2.20 MLong-term operating lease liabilities, net of current portionLong-term operating lease liabilities, net$67.47 MRestricted cashRestricted cash$235.00 KEquityEquity$768.16 MOther long-term liabilitiesOther long-term liabilities$29.44 MLong-term reserve for income tax liabilitiesLong-term reserve for income tax liabilities$5.93 MNon-current assetsNon-current assets$1.11 BGross equity (calculated)Gross equity(calculated)$1.26 BGoodwill and intangible assets, netGoodwill and intangible assets, net$647.83 MRetained earningsRetained earnings$703.65 MProperty, plant, and equipmentProperty, plant, and equipment$316.06 MOperating lease right-of-use assetsOperating lease right-of-use assets$72.91 MDeferred tax assetsDeferred tax assets$42.46 MAdditional paid-in capitalAdditional paid-in capital$553.00 MOther assetsOther assets$33.39 MCommon stock: par value $0.0001; 300,000,000 shares authorized; 62,306,254 and 42,532,225 shares issued and outstanding, respectively, as of June 30, 2026 and 61,779,883 and 45,645,497 shares issued and outstanding, respectively, as of December 31, 2025Common stock: par value $0.0001$6.00 KFinance lease right-of-use assetsFinance lease right-of-use assets$152.00 KTreasury stockTreasury stock−$482.60 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$5.90 M
Chart details

Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,743,766,000 US dollars
Current assets
630,951,000 US dollars
Non-current assets
1,112,815,000 US dollars
Liabilities
975,609,000 US dollars
Current liabilities
263,205,000 US dollars
Non-current liabilities
712,404,000 US dollars
Equity
768,157,000 US dollars
Cash and cash equivalents
223,614,000 US dollars
Inventories
179,907,000 US dollars
Accounts receivable, net
144,857,000 US dollars
Short-term investments
66,509,000 US dollars
Prepaid expenses and other assets
11,001,000 US dollars
Income tax refunds and deposits
2,628,000 US dollars
Restricted short-term investments
2,200,000 US dollars
Restricted cash
235,000 US dollars
Goodwill and intangible assets, net
647,833,000 US dollars
Property, plant, and equipment
316,063,000 US dollars
Operating lease right-of-use assets
72,911,000 US dollars
Deferred tax assets
42,464,000 US dollars
Other assets
33,392,000 US dollars
Finance lease right-of-use assets
152,000 US dollars
Accounts payable and accrued liabilities
251,371,000 US dollars
Current portion of operating lease liabilities
8,800,000 US dollars
Current portion of long-term debt
2,488,000 US dollars
Income taxes payable
546,000 US dollars
Long-term debt, net of current portion and unamortized debt issuance costs
609,564,000 US dollars
Long-term operating lease liabilities, net of current portion
67,470,000 US dollars
Other long-term liabilities
29,444,000 US dollars
Long-term reserve for income tax liabilities
5,926,000 US dollars
Retained earnings
703,649,000 US dollars
Additional paid-in capital
553,002,000 US dollars
Common stock: par value $0.0001; 300,000,000 shares authorized; 62,306,254 and 42,532,225 shares issued and outstanding, respectively, as of June 30, 2026 and 61,779,883 and 45,645,497 shares issued and outstanding, respectively, as of December 31, 2025
6,000 US dollars
Treasury stock
negative 482,596,000 US dollars
Accumulated other comprehensive loss
negative 5,904,000 US dollars
Gross equity (calculated)
1,256,657,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!